本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Biohaven Pharmaceutical Holding Co Ltd.

12.71
-0.0800-0.63%
盤後12.930.2200+1.73%19:30 EDT
成交量:286.33萬
成交額:3,670.82萬
市值:19.12億
市盈率:-2.84
高:13.37
開:13.03
低:12.58
收:12.79
52周最高:18.57
52周最低:7.48
股本:1.50億
流通股本:1.18億
量比:0.77
換手率:2.43%
股息:- -
股息率:- -
每股收益(TTM):-4.4800
每股收益(LYR):-6.8648
淨資產收益率:-799.46%
總資產收益率:-71.98%
市淨率:156.42
市盈率(LYR):-1.85

資料載入中...

2023/10/06

重要事件披露

Form 8-K - Current report
2023/10/03

重要事件披露

Form 8-K - Current report
2023/09/27

重要事件披露

Form 8-K - Current report
2023/07/31

重要事件披露

Form 8-K - Current report
2023/07/31

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/29

重要事件披露

Form 8-K - Current report
2023/05/31

重要事件披露

Form 8-K - Current report
2023/05/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/12

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/05/12

重要事件披露

Form 8-K - Current report
2022/10/04

交易所摘牌聲明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2022/10/03

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/10/03

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/10/03

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/10/03

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/10/03

重要事件披露

8-K - Current report
2022/09/29

重要事件披露

8-K - Current report
2022/09/27

重要事件披露

8-K - Current report
2022/09/23

重要事件披露

8-K - Current report
2022/09/23

重要事件披露

8-K - Current report